Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide

被引:65
作者
McNairy, M
Gardetto, N
Clopton, P
Garcia, A
Krishnaswamy, P
Kazanegra, R
Ziegler, M
Maisel, AS
机构
[1] Vet Affairs Med Ctr, Div Cardiol, San Diego, CA USA
[2] Vet Affairs Med Ctr, Dept Med, San Diego, CA USA
[3] Vet Affairs Med Ctr, Dept Nursing, San Diego, CA USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
关键词
D O I
10.1067/mhj.2002.120148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background B-natriuretic peptide (BNP), a neurohormone secreted from the cardiac ventricles, reflects left ventricular pressure and correlates to disease severity and prognosis. The fact that BNP levels can now be measured by a rapid assay suggests its potential usefulness in the outpatient clinic. However, if patient activity were to markedly alter BNP levels, its use would be less attractive for monitoring patients in the outpatient clinical setting, Methods A total of 30 patients (10 normal, 10 New York Heart Association [NYHA] class I-II, 10 NYHA class III-IV) exercised with an upright bicycle protocol. Exercise was carried out to 75% of maximum heart rate, and venous blood was sampled before, immediately after, and 1 hour after completion of exercise. Plasma levels of BNP, epinephrine, and norepinephrine were measured. Results BNP levels at baseline were 29 +/- 11 pg/mL for normal subjects, 126 +/- 26 pg/mL for NYHA I-II subjects, and 1712 +/- 356 pg/mL for NYHA III-IV subjects. The change in BNP levels with exercise was significantly lower than the change in epinephrine and norepinephrine (P <.00 1). In normal subjects, BNP increased from 29 pg/mL to 44 pg/mL with peak exercise, still within the range of normal (<1 00 pg/mL). This is compared with larger increases of norepinephrine (716 pg/mL to 1278 pg/mL) and epinephrine (52 pg/mL to 86 pg/mL) with exercise in normal subjects. There were also only small increases in BNP with exercise in patients with congestive heart failure (NYHA I-II, 30%; NYHA III-IV, 18%). For the same groups, epinephrine levels increased by 218% and 312%, respectively, and norepinephrine levels increased by 232% and 163%, respectively. One hour after completion of exercise, there were only minimal changes in BNP levels from baseline state in normal subjects (+0.9%) and patients with NYHA I-II (3.8%). In patients with NYHA III-IV, there was a 15% increase from baseline 1 hour after exercise. Conclusions BNP levels show only minor changes with vigorous exercise, making it unlikely that a normal patient would be classified as having congestive heart failure based on a BNP level obtained after activity. Prior activity should not influence BNP levels in patients with congestive heart failure. Therefore, when a patient presents to clinic with a marked change in their BNP level, it may reflect a real change in their condition.
引用
收藏
页码:406 / 411
页数:6
相关论文
共 38 条
  • [1] *AM HEART ASS, 1996, HEART STROK FACTS 19, P15
  • [2] Effects of exercise on natriuretic peptides and cardiac function in man
    Barletta, G
    Stefani, L
    Del Bene, R
    Fronzaroli, C
    Vecchiarino, S
    Lazzeri, C
    Fantini, F
    La Villa, G
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 65 (03) : 217 - 225
  • [3] A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study
    Cheng, V
    Kazanagra, R
    Garcia, A
    Lenert, L
    Krishnaswamy, P
    Gardetto, N
    Clopton, P
    Maisel, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 386 - 391
  • [4] Natriuretic peptides - Relevance in cardiovascular disease
    Cheung, BMY
    Kumana, CR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (23): : 1983 - 1984
  • [5] PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE
    COHN, JN
    LEVINE, TB
    OLIVARI, MT
    GARBERG, V
    LURA, D
    FRANCIS, GS
    SIMON, AB
    RECTOR, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) : 819 - 823
  • [6] COWIE MR, 1997, LANCET, V350, P1347
  • [7] Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators
    Daggubati, S
    Parks, JR
    Overton, RM
    Cintron, G
    Schocken, DD
    Vesely, DL
    [J]. CARDIOVASCULAR RESEARCH, 1997, 36 (02) : 246 - 255
  • [8] Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
    Dao, Q
    Krishnaswamy, P
    Kazanegra, R
    Harrison, A
    Amirnovin, R
    Lenert, L
    Clopton, P
    Alberto, J
    Hlavin, P
    Maisel, AS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 379 - 385
  • [9] PLASMA BRAIN NATRIURETIC PEPTIDE IN ASSESSMENT OF ACUTE DYSPNEA
    DAVIS, M
    ESPINER, E
    RICHARDS, G
    BILLINGS, J
    TOWN, I
    NEILL, A
    DRENNAN, C
    RICHARDS, M
    TURNER, J
    YANDLE, T
    [J]. LANCET, 1994, 343 (8895) : 440 - 444
  • [10] Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials
    Dibbs, Z
    Thornby, J
    White, BG
    Mann, DL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) : 1935 - 1942